Dashboard
Manage Tickers

GLPG


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-tripcom-group-shares-are-trading-higher-by-around-10-here-are-20-stocks-moving-premarket
Why Trip.com Group Shares Are Trading High...
08/27/2024 09:48:21

major-investor-says-galapagos-is-undervalued-plans-to-push-on-companys-performance-and-strategic-opportunities
Major Investor Says Galapagos Is 'Underval...
08/26/2024 16:38:02

Galapagos stock rises as EcoR1 Capital discloses a 9.9% stake and plans to engage on business and governance. Investor sees sha...

galapagos-xpeng-cormedix-and-other-big-stocks-moving-higher-on-monday
Galapagos, XPeng, CorMedix And Other Big S...
08/26/2024 13:59:41

ecor1-capital-reported-a-99-stake-in-galapagos-on-friday-in-a-13d-filing
Ecor1 Capital Reported A 9.9% Stake In Gal...
08/26/2024 10:57:40

why-mira-pharmaceuticals-shares-are-trading-higher-by-around-45-here-are-20-stocks-moving-premarket
Why MIRA Pharmaceuticals Shares Are Tradin...
08/26/2024 09:58:17

galapagos-gets-fda-nod-for-ind-application-on-phase-12-atalanta-1-study-of-cd19-car-t-therapy-glpg5101-in-refractory-non-hodgkin-lymphoma
Galapagos Gets FDA Nod For IND Application...
08/23/2024 05:52:06

Galapagos NV announced that the U.S. Food and Drug Administration (FDA) has cleared Galapagos' Investigational New Drug (IN...

galapagos-receives-transparency-notification-from-fmr-llc-holding-561-of-voting-rights-fmr-llcs-position-includes-3693550-ordinary-shares-and-3200-financial-instruments-remaining-above-the-5-threshold
Galapagos Receives Transparency Notificati...
08/20/2024 20:05:17

Pursuant to Belgian transparency legislation1, Galapagos received a transparency notification on 16 August 2024 from FMR LLC, w...

fda-approves-adaptimmune-therapeutics-engineered-cell-therapy-as-first-for-solid-tumor-and-new-therapy-for-rare-soft-tissue-cancer-in-over-a-decade
FDA Approves Adaptimmune Therapeutics' Eng...
08/02/2024 12:46:46

FDA approves Adaptimmune Therapeutics' Tecelra for unresectable or metastatic synovial sarcoma, a rare cancer near large jo...

galapagos-q2-2024-adj-eps-151-beats-004-estimate-sales-14030m-beat-6475m-estimate
Galapagos Q2 2024 Adj EPS $1.51 Beats $(0....
08/01/2024 20:06:43

Galapagos (NASDAQ:GLPG) reported quarterly earnings of $1.51 per share which beat the analyst consensus estimate of $(0.04) by ...

bridgene-biosciences-expands-collaboration-with-galapagos-nv-eligible-to-receive-up-to-159m-in-total-payments-partnership-focuses-on-discovery-of-highly-selective-oral-smarca2-protac
BridGene Biosciences Expands Collaboration...
08/01/2024 20:02:49

galapagos-to-present-data-on-cd19-car-t-candidate-glpg5101-for-relapsedrefractory-non-hodgkin-lymphoma-at-eha-2024
Galapagos To Present Data On CD19 CAR-T Ca...
06/14/2024 20:03:11

Core News & Articles
Galapagos And Adaptimmune Enter Clinical C...
05/30/2024 20:02:10

Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next gener...

galapagos-and-blood-centers-of-america-collaborate-to-expand-galapagos-decentralized-car-t-manufacturing-network-in-the-us
Galapagos And Blood Centers Of America Col...
05/15/2024 20:03:06

BCA's national network of blood centers will provide decentralized manufacturing services for Galapagos' CAR-T product ...

galapagos-q1-eps-140-vs-040-yoy-revenue-624-million-vs-586-million-yoy
Galapagos Q1 EPS €1.40 Vs €0.40 YoY; Reven...
05/02/2024 20:37:56

Results from our continuing operationsTotal operating loss from continuing operations for the three months ended 31 March 2024 ...

morgan-stanley-maintains-equal-weight-on-galapagos-maintains-38-price-target
Morgan Stanley Maintains Equal-Weight on G...
04/22/2024 17:23:34

Morgan Stanley analyst Judah Frommer maintains Galapagos (NASDAQ:GLPG) with a Equal-Weight and maintains $38 price target.

galapagos-plans-clinical-and-translational-data-presentations-at-ebmt-congress-2024
Galapagos Plans Clinical And Translational...
04/04/2024 20:03:43

Two oral presentations and one poster on encore preliminary data from Phase 1/2 CD19 CAR-T studies in non-Hodgkin lymphoma (NHL...

galapagos-downgraded-pharma-firm-faces-uphill-battle-with-slow-pipeline-progress-analyst
Galapagos Downgraded, Pharma Firm Faces Up...
04/01/2024 18:37:03

BofA Securities downgrades Galapagos to underperform due to limited near-term catalysts and competitive challenges in crowded m...

b-of-a-securities-downgrades-galapagos-to-underperform-lowers-price-target-to-31
B of A Securities Downgrades Galapagos to ...
04/01/2024 11:07:37

B of A Securities analyst Jason Gerberry downgrades Galapagos (NASDAQ:GLPG) from Neutral to Underperform and lowers the pric...

b-of-a-securities-downgrades-galapagos-to-underperform-lowers-price-target-to-31
B of A Securities Downgrades Galapagos to ...
03/28/2024 10:20:03

B of A Securities analyst Jason Gerberry downgrades Galapagos (NASDAQ:GLPG) from Neutral to Underperform and lowers the pric...

morgan-stanley-assumes-galapagos-at-equal-weight-announces-price-target-of-38
Morgan Stanley Assumes Galapagos at Equal-...
03/07/2024 09:20:00

Morgan Stanley analyst Judah Frommer assumes Galapagos (NASDAQ:GLPG) with a Equal-Weight rating and announces Price Target o...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION